CIK 0001095981 · Non-accelerated filer<br>Smaller reporting company
CERENOME, INC.
Sign in to watch- Ticker
- CNSY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330827593
- Phone
- 737.255.7194
- Business address
- 6420 LEVIT GREEN BOULEVARD, SUITE 310, HOUSTON, TX, 77021
- Former names
- PLUS THERAPEUTICS, INC., CYTORI THERAPEUTICS, INC., MACROPORE INC
- 8-K Event Executive or director change
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Delisting notice
- 8-K Event Material agreement · Agreement ended · New debt or obligation · Unregistered share sale · Executive or director change
- 4 Grant or award Director acquired 19,424 shares (grant or award)
- 4 Grant or award Director acquired 12,440 shares (grant or award)
- 4 Grant or award Director acquired 42,785 shares (grant or award)
- 4 Grant or award Director acquired 34,228 shares (grant or award)
- SC 13G Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- 4 Open-market sale 10% owner sold 600,000 shares at $1.37 ($822,540)
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Other events
Page 38 of 74 · 1,465 filings